Jessica Donington to Aged
This is a "connection" page, showing publications Jessica Donington has written about Aged.
Connection Strength
0.662
-
Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2024 Jul; 25(5):440-448.
Score: 0.069
-
Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapy. J Thorac Cardiovasc Surg. 2024 Oct; 168(4):1261-1269.e1.
Score: 0.068
-
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
Score: 0.055
-
STS 2019 Workforce Report: Ad Hoc Analysis of Women in Cardiothoracic Surgery. Ann Thorac Surg. 2021 02; 111(2):383-385.
Score: 0.055
-
Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 11; 160(5):1331-1345.e1.
Score: 0.053
-
The WTS report on the current status of women in cardiothoracic surgery. Ann Thorac Surg. 2012 Aug; 94(2):452-8; discussion 458-9.
Score: 0.031
-
Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomark. 2012; 12(4):177-84.
Score: 0.030
-
Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer. J Clin Oncol. 2010 Feb 20; 28(6):936-41.
Score: 0.026
-
Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006 Oct; 1(8):802-9.
Score: 0.021
-
Implementing a Frailty-Specific Postoperative Order Set to Improve Postoperative Outcomes in Frail Adults After Elective Thoracic Surgery. J Nurs Care Qual. 2024 Oct-Dec 01; 39(4):361-368.
Score: 0.018
-
Cost effectiveness of commercial portable ex vivo lung perfusion at a low-volume US lung transplant center. Artif Organs. 2024 Nov; 48(11):1288-1296.
Score: 0.018
-
Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus. Ann Thorac Surg. 2004 Apr; 77(4):1193-8; discussion 1198-9.
Score: 0.017
-
Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility. J Clin Oncol. 2024 Jun 10; 42(17):2026-2037.
Score: 0.017
-
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2024 May; 19(5):749-765.
Score: 0.017
-
Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg. 2003 Oct; 24(4):631-6; discussion 636-7.
Score: 0.017
-
Impact of Federal Lung Cancer Screening Policy on the Incidence of Early-stage Lung Cancer. Ann Thorac Surg. 2023 04; 115(4):827-833.
Score: 0.016
-
Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy. Ann Thorac Surg. 2002 Jul; 74(1):154-8; discussion 158-9.
Score: 0.015
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.015
-
Evaluation of the airway microbiome in nontuberculous mycobacteria disease. Eur Respir J. 2018 10; 52(4).
Score: 0.012
-
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. J Thorac Oncol. 2017 09; 12(9):1413-1420.
Score: 0.011
-
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma. J Thorac Oncol. 2016 06; 11(6):900-9.
Score: 0.010
-
Treatment of recalcitrant subcutaneous emphysema using negative pressure wound therapy dressings. BMJ Case Rep. 2014 Nov 09; 2014.
Score: 0.009
-
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med. 2012 Oct 11; 367(15):1417-27.
Score: 0.008
-
A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg. 2012 Sep; 115(3):694-702.
Score: 0.008
-
Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer. Clin Lung Cancer. 2011 Sep; 12(5):280-5.
Score: 0.007
-
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2011 May; 6(5):920-6.
Score: 0.007
-
Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol. 2010 Oct; 5(10):1649-54.
Score: 0.007
-
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res. 2010 Mar 01; 70(5):1916-24.
Score: 0.007
-
Initial experience with endobronchial ultrasound in an academic thoracic surgery program. Clin Lung Cancer. 2010 Jan; 11(1):25-9.
Score: 0.006
-
Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007 Oct 01; 69(2):328-33.
Score: 0.006
-
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res. 2006 Mar 01; 12(5):1507-14.
Score: 0.005
-
Recurrence of pulmonary intravascular bronchoalveolar tumor with mediastinal metastasis 20 years later. Respir Med. 2006 Feb; 100(2):367-70.
Score: 0.005